Pharmaxis Ltd adds combination treatment arm to Phase 2 myelofibrosis study
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) plans to accelerate a combination study for its lead PXS-5505 drug candidate in myelofibrosis patients following a US...
Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) plans to accelerate a combination study for its lead PXS-5505 drug candidate in myelofibrosis patients following a US...
Deep Dive - Pharmaxis Ltd
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has strengthened its board through the appointment of experienced life sciences investment professional Hashan De Silva...
Sydney, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...